Immuno-Oncology NewsNovartis Joins Harvard and Dana-Farber to Develop Delivery Systems for ImmunotherapiesImmuno-Oncology News“We look forward to collaborating with the Wyss Institute to further develop this technology in conjunction with our growing i… Continue reading
American Veterinarian |
Feline Mesenchymal Stem Cells: What’s Known and What’s Possible
American Veterinarian For a recent review paper, Jessica M. Quimby, DVM, PhD, DACVIM, associate professor of internal medicine in the Department of Veterinary Clinical Sciences at The Ohio State University in Columbus, and Dori L. Borjesson, BA, DVM, MPVM, PhD, professor of … |
Medscape |
‘Big Deal’: NCCN Guide for Immunotherapy Adverse Events
Medscape ORLANDO, Florida — The National Comprehensive Cancer Network (NCCN) has introduced a new guideline on immunotherapy adverse events. Immunotherapy with checkpoint inhibitors has had a huge impact on the treatment of many different types of cancer … |
Medscape |
‘Big Deal’: NCCN Guide for Immunotherapy Adverse Events
Medscape ORLANDO, Florida — The National Comprehensive Cancer Network (NCCN) has introduced a new guideline on immunotherapy adverse events. Immunotherapy with checkpoint inhibitors has had a huge impact on the treatment of many different types of cancer … |